Your browser is no longer supported. Please, upgrade your browser.
VRX Valeant Pharmaceuticals International, Inc. daily Stock Chart
Valeant Pharmaceuticals International, Inc.
Index- P/E- EPS (ttm)-5.40 Insider Own2.30% Shs Outstand350.70M Perf Week0.54%
Market Cap7.79B Forward P/E6.25 EPS next Y3.55 Insider Trans0.88% Shs Float347.66M Perf Month27.07%
Income-1892.00M PEG- EPS next Q0.77 Inst Own66.80% Short Float6.19% Perf Quarter21.51%
Sales8.61B P/S0.90 EPS this Y158.60% Inst Trans20.01% Short Ratio2.19 Perf Half Y42.58%
Book/sh12.61 P/B1.76 EPS next Y4.84% ROA-2.40% Target Price17.14 Perf Year66.79%
Cash/sh2.59 P/C8.56 EPS next 5Y-0.11% ROE-18.80% 52W Range10.94 - 24.43 Perf YTD6.83%
Dividend- P/FCF5.02 EPS past 5Y66.20% ROI9.80% 52W High-9.13% Beta-0.33
Dividend %- Quick Ratio0.90 Sales past 5Y20.20% Gross Margin70.70% 52W Low102.93% ATR0.72
Employees20700 Current Ratio1.20 Sales Q/Q-5.40% Oper. Margin-28.70% RSI (14)82.16 Volatility2.15% 3.55%
OptionableYes Debt/Eq5.89 EPS Q/Q-528.60% Profit Margin-10.70% Rel Volume0.61 Prev Close22.03
ShortableYes LT Debt/Eq5.71 EarningsMay 08 BMO Payout- Avg Volume9.83M Price22.20
Recom3.00 SMA2012.32% SMA5025.41% SMA20032.24% Volume5,988,637 Change0.77%
Apr-06-18Upgrade Mizuho Underperform → Neutral $10 → $15
Jan-24-18Initiated Goldman Sell $18
Jan-16-18Reiterated H.C. Wainwright Buy $17 → $24
Dec-15-17Reiterated Mizuho Underperform $7 → $10
Dec-14-17Downgrade JP Morgan Neutral → Underweight
Aug-03-17Reiterated RBC Capital Mkts Sector Perform $19 → $21
Jun-16-17Initiated Cantor Fitzgerald Overweight $18
May-10-17Reiterated RBC Capital Mkts Sector Perform $18 → $19
Apr-20-17Reiterated JP Morgan Neutral $15 → $10
Mar-23-17Reiterated RBC Capital Mkts Sector Perform $21 → $18
Mar-06-17Reiterated Rodman & Renshaw Neutral $23 → $17
Feb-27-17Reiterated Mizuho Underperform $11 → $9
Feb-14-17Reiterated RBC Capital Mkts Sector Perform $29 → $22
Feb-10-17Reiterated Barclays Equal Weight $34 → $20
Jan-04-17Reiterated Piper Jaffray Underweight $16 → $11
Dec-15-16Downgrade Morgan Stanley Overweight → Equal-Weight $25 → $17
Nov-23-16Downgrade Mizuho Neutral → Underperform $25 → $11
Nov-14-16Reiterated Deutsche Bank Hold $29 → $24
Nov-10-16Reiterated Morgan Stanley Overweight $42 → $25
Nov-10-16Downgrade Rodman & Renshaw Buy → Neutral $81 → $23
May-23-18 01:00AM  [$$] Jury Finds Former Valeant Exec Guilty on Charges Related to Kickback Scheme The Wall Street Journal
12:15AM  [$$] A closer look at the great Maryland pension fees debate Financial Times
May-22-18 02:15PM  Former CEO of Hatboro mail-order pharmacy convicted of fraud, money laundering charges American City Business Journals
02:05PM  [$$] Former Valeant Exec Found Guilty on Charges Related to Kickback Scheme The Wall Street Journal
01:44PM  Ex-Valeant, Philidor executives convicted of kickback scheme Reuters
01:25PM  Ex-Valeant Executive Guilty of Taking Pharmacy CEOs Bribe Fortune
01:18PM  Jury Finds Former Valeant Exec Guilty on Charges Related to Kickback Scheme The Wall Street Journal
10:58AM  Ex-Valeant Executive Guilty of Taking Pharmacy CEOs Bribe Bloomberg
May-21-18 11:00PM  [$$] Leveraged loan rush sees borrowers gain balance of power Financial Times
May-19-18 04:10PM  Cantor Fitzgerald: 18 Drug Companies With Catalysts Worth Watching Benzinga
May-18-18 12:35AM  Ackman Has a Point About United Technologies Corporation Stock InvestorPlace
May-17-18 05:00PM  Valeant Announces Pricing Of Private Offering Of Notes PR Newswire
10:48AM  Valeant Pharmaceuticals International, Inc -- Moody's assigns Caa1 to Valeant's unsecured notes; outlook stable Moody's
07:22AM  Valeant launches $750 million bond offering, increases planned Term B loan borrowing MarketWatch
07:15AM  Valeant Announces Launch Of Private Offering Of Notes And Upsize Of Term Loans PR Newswire
May-16-18 08:20AM  Today's Research Reports on Trending Tickers: Celgene and Valeant Pharmaceuticals ACCESSWIRE
May-15-18 02:44PM  Valeant Ex-CEO Wasn't Swayed by Philidor Warning, Witness Says Bloomberg
12:40PM  Valeant Pharmaceuticals International, Inc -- Moody's assigns Ba3 to Valeant's new credit facilities; outlook stable Moody's
11:00AM  Valeant: Turning Around or Just Spinning?
09:23AM  Stocks to Watch: Home Depot, Amazon, Symantec, Wynn, CBS, Viacom, Tesla, Ford, Micron, Valeant The Wall Street Journal
08:00AM  Valeant to Participate at the 2018 Barclays High Yield Bond and Syndicated Loan Conference PR Newswire
07:49AM  VRX Investor Alert: Kyros Law Announces that it is Filing Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors PR Newswire
07:00AM  Bill Ackmans Big Deals Dont Look Better in Hindsight Bloomberg
May-14-18 03:03PM  Ex-Valeant Official Says He Suspected Secret Financial Stake Bloomberg
May-13-18 10:18AM  Barron's Picks And Pans: Arista, Kroger, SeaWorld, Valeant And More Benzinga
May-11-18 10:14AM  AT&T CEO calls Cohen hiring a mistake, Barclays CEO pays fine, JPM reportedly focuses on electronic trading Yahoo Finance Video
May-10-18 03:21PM  Valeant (VRX) Rallies on Earnings Beat in Q1, Raises View Zacks
08:30AM  Valeant To Participate At 2018 Bank Of America Merrill Lynch Healthcare Conference PR Newswire
07:16AM  Valeant will borrow more than $3.82 bln MarketWatch
07:00AM  Valeant To Seek Refinancing of its Existing Credit Agreement PR Newswire
May-09-18 01:07PM  Valeant Earnings: One Day Later, Shares Are Still Rising
11:34AM  Jim Cramer on Bausch Health: This Stock Is a Buy
09:05AM  Wednesdays Vital Data: Valeant Pharmaceuticals Intl Inc (VRX), Walt Disney Co (DIS) and Citigroup Inc (C) InvestorPlace
08:52AM  Valeant Pharmaceuticals (VRX) Catches Eye: Stock Jumps 8.9% Zacks
08:30AM  Today's Research Reports on Trending Tickers: OPKO Health and Valeant Pharmaceuticals ACCESSWIRE
07:00AM  4 Top Stock Trades for Wednesday Morning InvestorPlace
06:57AM  Valeant will get a new name to shed its scandals, but will it work? MarketWatch
May-08-18 07:19PM  Valeant Pharma CEO: Seeing organic growth for first time ... CNBC Videos +8.87%
07:00PM  Cramer Remix: GE just got a huge breakthe stock may have bottomed CNBC
06:53PM  For the first time since 2015, we're seeing organic growt... CNBC Videos
06:20PM  For the first time since 2015, we're seeing organic growth: Valeant Pharma CEO CNBC
04:29PM  Why Expeditors International of Washington, Valeant Pharmaceuticals International, and SeaWorld Entertainment Jumped Today Motley Fool
04:11PM  Dow Trims Earlier Losses, Finishes Slightly Higher After Volatile Session
03:30PM  Valeant: A 'Turnaround for the Ages'?
03:02PM  Valeant Pharmaceuticals' Turnaround Gains Momentum With a Better-Than-Expected First Quarter Motley Fool
02:06PM  Valeant Pharmatceuticals Debt Wont Be Fooled by a Name Change InvestorPlace
01:59PM  One of Tampa Bays biggest health care manufacturers changes its name American City Business Journals
12:06PM  Valeant tries to leave the past behind with name change, shares surge Reuters
11:58AM  Valeant tries to leave the past behind with name change, shares surge Reuters
10:57AM  Top 3 Companies Owned by Valeant Investopedia
10:51AM  [$$] Valeant Returns to Organic Revenue Growth The Wall Street Journal
10:43AM  Valeant Upside, Shire Buyout Don't Rally Pharma Stocks
10:29AM  Can a Bold Name Change Help Valeant Escape Its Tarnished Reputation?
10:21AM  Valeant smashes earnings, Elon Musk bets big on Tesla, C-Suite shake-up at Snap Yahoo Finance Video
10:09AM  Valeant Posts Q1 Earnings Beat, Announces Name Change To Bausch Health Benzinga
09:36AM  Valeant, a new business model and now, a new name Associated Press
09:27AM  Stocks to Watch: Citigroup, 21st Century Fox, Disney, Amazon, Snap, Valeant, Macy's, Dish, Dean Foods The Wall Street Journal
08:18AM  Valeant Pharma to rename itself as Bausch Health, lifts revenue outlook Reuters
07:55AM  Benzinga's Daily Biotech Pulse: Valeant Earnings, Lipocine's FDA Watch, Invivo CFO Departure Benzinga
07:32AM  Jim Cramer Advises His Viewers On Prestige Brands, CVS Health And More Benzinga
07:21AM  Valeant: 1Q Earnings Snapshot Associated Press
07:14AM  Valeant shares surge 5% on Q1 revenue beat, higher guidance MarketWatch
07:00AM  Valeant Will Become Bausch Health Companies Inc. PR Newswire
07:00AM  Valeant Announces First-Quarter 2018 Results And Raises Revenue And Adjusted EBITDA (non-GAAP) Guidance PR Newswire
06:34AM  PRESS DIGEST- Canada-May 8 Reuters
06:00AM  Valeant Pharmaceuticals International Inc to Host Earnings Call ACCESSWIRE
12:41AM  [$$] Valeant Pharmaceuticals to Change Its Name to Bausch Health The Wall Street Journal
12:11AM  [$$] Valeant Pharmaceuticals to Change Its Name to Bausch Health The Wall Street Journal
May-07-18 07:30PM  Safirstein Metcalf LLP and HGT Law Remind Investors That a Shareholder Opt-out Lawsuit was Filed on Behalf of Retail Investors and Invite Investors to Contact the Firms - VRX GlobeNewswire
10:53AM  Valeant Stock Moves Higher After FDA Approves Bowel Cleanser Benzinga
09:24AM  Morning Movers: Starbucks Surges, Valeant Rises, Shake Shack Slumps
08:30AM  Drug/Biotech Q1 Earnings Lineup on May 8: JAZZ, ARNA & More Zacks
08:00AM  Bausch + Lomb Launches LUMIFY, The First And Only OTC Redness Relieving Eye Drop With Low-Dose Brimonidine PR Newswire
07:00AM  Salix Receives FDA Approval For PLENVU®, Next Generation 1-Liter Bowel Cleansing Preparation For Colonoscopies PR Newswire
May-03-18 03:49PM  How Strategist Steve Sosnick Is Trading Valeant Bloomberg Video
03:49PM  How Strategist Steve Sosnick Is Trading Valeant Bloomberg
02:13PM  Ex-Valeant exec's lawyers urge jury to reject fraud charge Reuters
12:46PM  Ex-Valeant Official Sought Big Payday in Bribe Scam, Jury Told Bloomberg
08:00AM  Valeant To Participate At Goldman Sachs Third Annual Leveraged Finance Conference PR Newswire
06:00AM  Ex-Valeant official accused of kickback scheme faces trial Reuters
May-02-18 08:00PM  Summary Judgment Granted Upholding The Validity Of Formulation Patent Protecting RELISTOR® Injection PR Newswire
12:14PM  Ex-Valeant Official's Trial Set to Revive Its Past Pain Bloomberg
08:26AM  Bausch + Lomb ULTRA® Contact Lenses Receive FDA Approval for Extended Wear Indication PR Newswire
May-01-18 08:10PM  Valeant Announces 2018 Annual Meeting Results CNW Group
11:41AM  [$$] Executive's Fraud Trial Puts Valeant in Uncomfortable Light The Wall Street Journal
Apr-27-18 08:00AM  Bausch + Lomb Will Present Scientific And Clinical Research During The Association For Research In Vision And Ophthalmology Meeting PR Newswire
Apr-26-18 12:50PM  Amid Negative Sentiment, Broadcom Inc Stock Offers a Buying Opportunity InvestorPlace
Apr-25-18 10:01AM  Allergan plc Stock Looks Cheap for Good Reasons InvestorPlace
Apr-21-18 12:26PM  Is Valeant Pharmaceuticals International Inc (NYSE:VRX) A Financially Sound Company? Simply Wall St.
Apr-19-18 08:57AM  Implied Volatility Surging for Valeant (VRX) Stock Options Zacks
08:00AM  Bausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through ONE by ONE Program PR Newswire
Apr-16-18 08:30AM  Todays Research Reports on Trending Tickers: Valeant Pharmaceuticals and Nektar Therapeutics ACCESSWIRE
Apr-13-18 11:51AM  Valeant Pharmaceuticals International Incs (NYSE:VRX) Insiders Ramped Up Holdings Should You? Simply Wall St.
11:39AM  Paulson, Ackman and Sequoia: The Investors Who Took a Beating on Valeant The Wall Street Journal
Apr-12-18 04:15PM  Valeant Announces Redemption of $150 Million Aggregate Principal Amount of Its Outstanding 6.375% Senior Unsecured Notes Due 2020 PR Newswire
02:51PM  Arbitral Tribunal Decides In Favor Of Valeant In UCERIS Arbitration PR Newswire
Apr-11-18 08:00AM  Bausch + Lomb to Showcase New Scientific Data During the Annual Meeting of the American Society of Cataract and Refractive Surgery PR Newswire
Apr-10-18 07:33PM  Valeant And One Of Its Subsidiaries Announce Expiration And Final Settlement Date For Cash Tender Offers For Senior Notes PR Newswire
Apr-09-18 07:45AM  New Research Coverage Highlights SINOPEC Shangai Petrochemical, Aurinia Pharmaceuticals, Valeant Pharmaceuticals International, NTT DOCOMO, Southern Missouri, and KNOT Offshore Partners LP Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
07:00AM  Ortho Dermatologics Announces Publication Of Pivotal Efficacy And Safety Data For Psoriasis Treatment DUOBRII In The Journal of the American Academy of Dermatology PR Newswire
Valeant Pharmaceuticals International, Inc. operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S. Diversified Products. The Bausch + Lomb/International segment provides pharmaceutical products, OTC products, and medical device products, primarily consist of Bausch + Lomb products, with a focus on the vision care, surgical, consumer, and ophthalmology Rx products in the United States; and pharmaceutical products, generic pharmaceutical products, OTC products, medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia and New Zealand, Latin America, Africa, and the Middle East. The Branded Rx segment sells gastrointestinal and dermatological products in the United States. The U.S. Diversified Products segment offers pharmaceutical products, OTC products, and medical device products in the areas of neurology and certain other therapeutic classes, including aesthetics. The company was founded in 1983 and is headquartered in Laval, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DE SCHUTTER RICHARD UDirectorMay 15Buy21.8315,000327,450133,383May 17 04:43 PM
Herendeen PaulEVP and CFOMar 13Buy16.1015,000241,470231,492Mar 13 04:43 PM
PAPA JOSEPH CCHAIRMAN & CEOMar 13Buy16.0530,000481,500719,019Mar 13 04:38 PM
DE SCHUTTER RICHARD UDirectorMar 08Buy15.3410,000153,400106,062Mar 12 08:59 PM
Paulson JohnDirectorMar 06Buy15.407,066,629108,826,08720,839,035Mar 08 05:04 PM
Paulson JohnDirectorMar 06Sale15.407,066,629108,826,08713,772,406Mar 08 05:04 PM
DE SCHUTTER RICHARD UDirectorNov 17Buy14.3310,000143,30094,559Nov 21 06:26 PM
Paulson JohnDirectorNov 16Buy14.40344,2164,955,50621,183,251Nov 20 06:00 PM
Paulson JohnDirectorNov 16Sale14.39344,2164,952,82120,839,035Nov 20 06:00 PM
DE SCHUTTER RICHARD UDirectorAug 21Buy14.3310,000143,29682,379Aug 22 04:39 PM